Works matching IS 10781552 AND DT 2020 AND VI 26 AND IP 7
Results: 40
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1676, doi. 10.1177/1078155220953198
- By:
- Publication type:
- Article
Development of a tool to allocate inpatient specialized pharmacy resources at a comprehensive cancer center.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1686, doi. 10.1177/1078155220952522
- By:
- Publication type:
- Article
Suggestion of Tunisia's medical oncologist in the management of breast cancer during COVID-19 pandemic.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1732, doi. 10.1177/1078155220948943
- By:
- Publication type:
- Article
The pharmacist's role in chimeric antigen receptor T cell therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1725, doi. 10.1177/1078155220948940
- By:
- Publication type:
- Article
Switch in use of midazolam for cancer patients during the COVID-19 pandemic.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Off-label infusion of biosimilar bevacizumab: A provincial experience.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1683, doi. 10.1177/1078155220945374
- By:
- Publication type:
- Article
Optimizing care for high-risk neuroblastoma patients treated with dinutuximab: Challenges for the multidisciplinary team.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1721, doi. 10.1177/1078155220941044
- By:
- Publication type:
- Article
Continuous-infusion and outpatient setting: A chance for patients, a challenge for hospital pharmacists.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1715, doi. 10.1177/1078155220937389
- By:
- Publication type:
- Article
Management of skin adverse reactions in oncology.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1703, doi. 10.1177/1078155220936341
- By:
- Publication type:
- Article
Are we aware of potential interactions between drugs used in lung cancer and drugs used in the treatment of COVID-19?
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Role of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1695, doi. 10.1177/1078155220934862
- By:
- Publication type:
- Article
Long-term response control in a patient with metastatic squamous cell lung cancer after treatment with nivolumab: a case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1802, doi. 10.1177/1078155220915774
- By:
- Publication type:
- Article
Posterior reversible encephalopathy syndrome: A rare neurotoxicity after capecitabine.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1795, doi. 10.1177/1078155220914704
- By:
- Publication type:
- Article
Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1791, doi. 10.1177/1078155220913081
- By:
- Publication type:
- Article
Pegfilgrastim-associated large-vessel vasculitis developed during adjuvant chemotherapy for breast cancer: A case report and review of the literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1785, doi. 10.1177/1078155220910800
- By:
- Publication type:
- Article
Safety of trastuzumab after trastuzumab emtansine-induced nodular regenerative hyperplasia: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1780, doi. 10.1177/1078155220910252
- By:
- Publication type:
- Article
Autoimmune hypophysitis secondary to therapy with immune checkpoint inhibitors: Four cases describing the clinical heterogeneity of central endocrine dysfunction.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1774, doi. 10.1177/1078155220910202
- By:
- Publication type:
- Article
Chemotherapy-induced pneumonitis associated with transient CA 15-3 elevation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1750, doi. 10.1177/1078155220904994
- By:
- Publication type:
- Article
Left ventricular dysfunction associated with axitinib and nivolumab experience in an advanced renal cell carcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1765, doi. 10.1177/1078155220909422
- By:
- Publication type:
- Article
Sweet's syndrome under ipilimumab therapy and a brief comparison of the cases in literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1762, doi. 10.1177/1078155220906885
- By:
- Publication type:
- Article
Real-time comprehensive toxicology testing in the clinical management of accidental pediatric capecitabine ingestion.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1759, doi. 10.1177/1078155220906266
- By:
- Publication type:
- Article
Treatment exceeds expectations with vemurafenib monotherapy in a patient with BRAF V600E -mutant metastatic melanoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1754, doi. 10.1177/1078155220906011
- By:
- Publication type:
- Article
Saddle pulmonary embolism with fluorouracil: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1769, doi. 10.1177/1078155220909424
- By:
- Publication type:
- Article
Advantages of everolimus therapeutic drug monitoring in oncology when drug–drug interaction is suspected: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1743, doi. 10.1177/1078155220904761
- By:
- Publication type:
- Article
Steatohepatitis due to FOLFIRINOX regimen in adjuvant pancreas cancer treatment mimicking liver metastasis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1738, doi. 10.1177/1078155220904422
- By:
- Publication type:
- Article
Bruton's tyrosine kinase inhibitors and the kidney: Focus on ibrutinib.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1735, doi. 10.1177/1078155220904406
- By:
- Publication type:
- Article
Effectiveness of a pharmaceutical instruction video for adherence to dermatopathy treatment in patients with cancer receiving the anti-epidermal growth factor receptor antibody.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1667, doi. 10.1177/1078155220904149
- By:
- Publication type:
- Article
The real-life outcome of pazopanib in patients with advanced soft tissue sarcoma: A retrospective cross-sectional study of a Turkish cohort.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1657, doi. 10.1177/1078155220904138
- By:
- Publication type:
- Article
Evaluation of the efficacy and safety of apixaban and rivaroxaban in cancer patients receiving concomitant active anti-neoplastic therapy at an outpatient cancer setting.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1650, doi. 10.1177/1078155220901777
- By:
- Publication type:
- Article
Evaluation of urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1643, doi. 10.1177/1078155220901756
- By:
- Publication type:
- Article
Prospective evaluation of drug–drug interactions in ambulatory cancer patients initiated on prophylactic anticoagulation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1637, doi. 10.1177/1078155220901569
- By:
- Publication type:
- Article
Centralization impact and cost-saving study in a Moroccan hospital's centralized unit of chemotherapy preparation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1630, doi. 10.1177/1078155220901336
- By:
- Publication type:
- Article
Toxicity, risk factors and management of cisplatin-induced toxicity: A prospective study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1621, doi. 10.1177/1078155219901305
- By:
- Publication type:
- Article
The impact of tumor regression grade on long-term survival in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1611, doi. 10.1177/1078155219900944
- By:
- Publication type:
- Article
Assessment of the relationship between methylenetetrahydrofolate reductase polymorphism and acute lymphoblastic leukemia: Evidence from an updated meta-analysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1598, doi. 10.1177/1078155219900914
- By:
- Publication type:
- Article
Evaluation of mobilization efficacy with an extended interval following plerixafor administration.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1590, doi. 10.1177/1078155219900909
- By:
- Publication type:
- Article
Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study).
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1583, doi. 10.1177/1078155219900908
- By:
- Publication type:
- Article
Protective effect of N-acetylcysteine on oxaliplatin-induced neurotoxicity in patients with colorectal and gastric cancers: A randomized, double blind, placebo-controlled, clinical trial.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1575, doi. 10.1177/1078155219900788
- By:
- Publication type:
- Article
Intraperitoneal paclitaxel and cisplatin compared with dose-dense paclitaxel and carboplatin for patients with stage III ovarian cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1566, doi. 10.1177/1078155219899460
- By:
- Publication type:
- Article
Application of KW-ANOVA statistics to generate evidence for cytotoxic drug wastage induced financial burden among cancer patients: A clinical pharmacist observation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1559, doi. 10.1177/1078155219898710
- By:
- Publication type:
- Article